Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Excess risk of hip fractures attributable to the use of antidepressants in five European countries and the USA.

Prieto-Alhambra D, Petri H, Goldenberg JS, Khong TP, Klungel OH, Robinson NJ, de Vries F.

Osteoporos Int. 2014 Mar;25(3):847-55. doi: 10.1007/s00198-013-2612-2. Epub 2014 Jan 22. Review.

PMID:
24448776
2.

Potential impact of benzodiazepine use on the rate of hip fractures in five large European countries and the United States.

Khong TP, de Vries F, Goldenberg JS, Klungel OH, Robinson NJ, Ibáñez L, Petri H.

Calcif Tissue Int. 2012 Jul;91(1):24-31. doi: 10.1007/s00223-012-9603-8. Epub 2012 May 8. Review.

3.

Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry.

Bakken MS, Engeland A, Engesæter LB, Ranhoff AH, Hunskaar S, Ruths S.

Age Ageing. 2013 Jul;42(4):514-20. doi: 10.1093/ageing/aft009. Epub 2013 Feb 24.

PMID:
23438446
4.

Forecasting the burden of future postmenopausal hip fractures.

Omsland TK, Magnus JH.

Osteoporos Int. 2014 Oct;25(10):2493-6. doi: 10.1007/s00198-014-2781-7. Epub 2014 Jul 1.

PMID:
24980184
5.

Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs.

Oderda LH, Young JR, Asche CV, Pepper GA.

Ann Pharmacother. 2012 Jul-Aug;46(7-8):917-28. doi: 10.1345/aph.1Q589. Epub 2012 Jul 17.

PMID:
22811347
6.

A study of the safety and harms of antidepressant drugs for older people: a cohort study using a large primary care database.

Coupland CA, Dhiman P, Barton G, Morriss R, Arthur A, Sach T, Hippisley-Cox J.

Health Technol Assess. 2011 Aug;15(28):1-202, iii-iv. doi: 10.3310/hta15280.

7.

Relationship between use of antidepressants and risk of fractures: a meta-analysis.

Rabenda V, Nicolet D, Beaudart C, Bruyère O, Reginster JY.

Osteoporos Int. 2013 Jan;24(1):121-37. doi: 10.1007/s00198-012-2015-9. Epub 2012 May 26.

PMID:
22638709
8.

The Impact of Disease and Drugs on Hip Fracture Risk.

Leavy B, Michaëlsson K, Åberg AC, Melhus H, Byberg L.

Calcif Tissue Int. 2017 Jan;100(1):1-12. doi: 10.1007/s00223-016-0194-7. Epub 2016 Sep 26.

9.

Antidepressant use and risk of adverse outcomes in older people: population based cohort study.

Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J.

BMJ. 2011 Aug 2;343:d4551. doi: 10.1136/bmj.d4551.

10.

The population attributable risk of nutrition and lifestyle on hip fractures.

Pripp AH, Dahl OE.

Hip Int. 2015 May-Jun;25(3):277-81. doi: 10.5301/hipint.5000229. Epub 2015 Apr 23. Review.

PMID:
25907388
11.

Serotonergic antidepressant use and the risk of fracture: a population-based nested case-control study.

Wang CY, Fu SH, Wang CL, Chen PJ, Wu FL, Hsiao FY.

Osteoporos Int. 2016 Jan;27(1):57-63. doi: 10.1007/s00198-015-3213-z. Epub 2015 Jul 1.

PMID:
26126579
12.

Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study.

Arbouw ME, Movig KL, van Staa TP, Egberts AC, Souverein PC, de Vries F.

Osteoporos Int. 2011 Jul;22(7):2197-204. doi: 10.1007/s00198-010-1455-3. Epub 2010 Oct 22.

13.

Treatment for older men with fractures.

Shepherd AJ, Cass AR, Ray LA, Tan A, Wilkinson GS.

Osteoporos Int. 2012 Mar;23(3):1041-51. doi: 10.1007/s00198-011-1681-3. Epub 2011 Aug 3.

PMID:
21811867
14.

The Risk of Hip Fracture Due to Mirtazapine Exposure When Switching Antidepressants or Using Other Antidepressants as Add-On Therapy.

Leach MJ, Pratt NL, Roughead EE.

Drugs Real World Outcomes. 2017 Dec;4(4):247-255. doi: 10.1007/s40801-017-0120-y.

15.

Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures.

Souverein PC, Abbing-Karahagopian V, Martin E, Huerta C, de Abajo F, Leufkens HG, Candore G, Alvarez Y, Slattery J, Miret M, Requena G, Gil MJ, Groenwold RH, Reynolds R, Schlienger RG, Logie JW, de Groot MC, Klungel OH, van Staa TP, Egberts TC, De Bruin ML, Gardarsdottir H.

Pharmacoepidemiol Drug Saf. 2016 Mar;25 Suppl 1:88-102. doi: 10.1002/pds.3862.

PMID:
27038355
16.
17.

Central nervous system active medications and risk for fractures in older women.

Ensrud KE, Blackwell T, Mangione CM, Bowman PJ, Bauer DC, Schwartz A, Hanlon JT, Nevitt MC, Whooley MA; Study of Osteoporotic Fractures Research Group.

Arch Intern Med. 2003 Apr 28;163(8):949-57.

18.

[Psychotropic drug use and mental psychiatric disorders in France; results of the general population ESEMeD/MHEDEA 2000 epidemiological study].

Gasquet I, Nègre-Pagès L, Fourrier A, Nachbaur G, El-Hasnaoui A, Kovess V, Lépine JP.

Encephale. 2005 Mar-Apr;31(2):195-206. French.

PMID:
15959446
19.

Use of anti-depressants and the risk of fracture of the hip or femur.

van den Brand MW, Pouwels S, Samson MM, van Staa TP, Thio B, Cooper C, Leufkens HG, Egberts AC, Verhaar HJ, de Vries F.

Osteoporos Int. 2009 Oct;20(10):1705-13. doi: 10.1007/s00198-009-0849-6. Epub 2009 Feb 24. Erratum in: Osteoporos Int. 2009 Oct;20(10):1715.

20.

Medication use before and after hip fracture: a population-based cohort and case-control study.

Rossini M, Viapiana O, Adami S, Idolazzi L, Buda S, Veronesi C, Degli Esposti L, Gatti D.

Drugs Aging. 2014 Jul;31(7):547-53. doi: 10.1007/s40266-014-0184-2.

PMID:
24825617

Supplemental Content

Support Center